Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix for Ovarian Stimulation in Breast Cancer Patients Before Chemotherapy
NCT03947151Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2019
- Primary completion
- Mar 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of degarelix in Hyperestrogenism, sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2019; status: completed.
02
Drugs
degarelix
03
Conditions
Hyperestrogenism
Beyond the preview
Go deeper on NCT03947151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03947151.